Aigen Investment Management, LP Dr Reddys Laboratories LTD Transaction History

Aigen Investment Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$61.9 - $72.77 $706,712 - $830,815	11,417 New	11,417 $763,000
Q1 2021 May 11, 2021	SELL	$57.98 - $73.08 $324,630 - $409,174	-5,599 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$62.61 - $71.29 $79,452 - $90,467	1,269 Added 29.31%	5,599 $399,000
Q3 2020 Nov 06, 2020	BUY	$51.39 - $72.41 $222,518 - $313,535	4,330 New	4,330 $301,000
Q2 2020 Aug 10, 2020	SELL	$39.55 - $54.65 $2,689 - $3,716	-68 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$34.75 - $45.85 $2,363 - $3,117	68 New	68 $3,000

253

34.9M

12.7K

6.1K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.29B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.